Human Diabetic Primary Kidney Fibroblast Cells
Quick Actions
Product Overview
Description
Human Diabetic Primary Kidney Fibroblast Cells are cryopreserved primary fibroblast cells intended for in vitro studies of diabetes-associated cellular dysfunction, tissue remodeling, signaling, and pharmacology. Early-passage use is recommended to reduce phenotype drift and preserve application-relevant behavior.
Guarantee expansion for a minimum of 2-6 population
doublings.
IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.
Key Features
Catalog Number: NBPDF008
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Passage:1(P1)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)
Characterization Markers
- Characterized by spindle morphology under light microscopy.
- Negative for von Willebrand Factor (vWF) , Cytokeratin 18,
and alpha-smooth muscle actin .
- Isolated and characterized to ensure fibroblast purity and identity.
Quick Facts
Product Type
Human Type II Diabetes Endothelial Cells
Viability
>95% viable (Trypan Blue exclusion)
Applications
Research & Development
Availability
In Stock • Global Shipping
Technical Specifications
Applications & Use Cases
Research Areas
In Vitro Studies
Cell culture and screening applications
Molecular Biology
Gene expression & signaling studies
Drug Discovery
Screening & validation studies
Disease Modeling
Pathophysiology research
Support & Resources
Technical Support
Our experts are available for technical questions and protocol assistance.
Contact Support
